Trial document





This trial has been registered retrospectively.
drksid header

  DRKS00014986

Trial Description

start of 1:1-Block title

Title

familiy-based evaluation of palliative care in the center part of Hesse

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

PallEva

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

https://palliativpro.de/ambulante-palliativ-teams/ambulantes-kinder-palliativ-team/projekt-palleva

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Quality of care is a new field in specialised home palliative care (shpc) teams in Germany. Not much published data are available so far. The intention of this study is to identify a tool to make the first step in finding best possible quality of care in shpc). The first step was to look at the literature and screen meaningful items for the families with palliative treated children (e.g. availability of shpc team or recognition of pain). After identification of these items a questionnaire for both, families and health care professionals was designed. A disparate evaluation could be an indication for a needed improvement of care (so-called blind spots).

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

After foundation of specialised home palliative care team for children in Giessen, Hesse, Germany there was a need to get an evaluation tool for quality of care. The basic approach of work in shpc teams is to view the whole families. So first question was which special needs these families have. After a view into the literature meaningful outcome parameters were identified and a questionnaire was designed. Families and health care professionals were asked 6 weeks to 6 month after ending of palliative care to answer the questionnaire. Items asked are: availability of the team, recognition of pain and relief of psychological symptoms. Answers were structured in a 1 (no agreement) to 10 (strong agreement) point scale. Strong different values could demonstrate the need for improvement of care.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

[---]*

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

[---]*

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00014986
  •   2018/08/06
  •   [---]*
  •   yes
  •   Approved
  •   189/15, Ethik-Kommission des Fachbereichs Medizin der Justus-Liebig-Universität Gießen
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   C71.9 -  Malignant neoplasm: Brain, unspecified
  •   G82.2 -  Paraplegia, unspecified
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   After an analysis of the literature meaningful outcome parameters were identified and a questionnaire was designed. Families and health care professionals were asked 6 weeks to 6 month after ending of palliative care to answer the questionnaire. Items asked are: availability of the team, recognition of pain and relief of psychological symptoms. Answers were structured in a 1 (no agreement) to 10 (strong agreement) point scale. Strong different values could demonstrate the need for improvement of care.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Other
  •   Open (masking not used)
  •   [---]*
  •   Other
  •   Health care system
  •   Other
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Measurement of quality of care based on the needs of families with a palliative treated child.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Measurement of rate of variability in a shpc team

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2017/11/01
  •   50
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Parents who agreed to the study after clarification

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

lack of agreement to the study

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • UKGM – Universitätsklinikum Gießen und Marburg, GmbH, Standort Gießen
    • Klinikstraße 33
    • 35392  Gießen
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • Medizinische Klinik V, Internistische Onkologie und Palliativmedizin, Universitätsklinikum Gießen und Marburg, Standort Gießen
    • Mr.  Dr. rer. med.  Daniel  Berthold 
    • Klinikstraße 33
    • 35392  Gießen
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • UKGM, Kinderpalliativteam
    • Mr.  Dr. med.  Holger  Hauch 
    • Kllinikstraße 33
    • 35394  Gießen
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • UKGM
    • Mr.  Dr. med.  Holger  Hauch 
    • Klinikstraße 33
    • 35392  Gießen
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • UKGM – Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen
    • Klinikstraße 33
    • 35392  Gießen
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
  • start of 1:1-Block address otherSupport
    • Friedhelm Wilmes-Stiftung
    • 35288  Wohratal
    • Germany
    end of 1:1-Block address otherSupport
    start of 1:1-Block address contact otherSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact otherSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.